Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease

Cell Death and Disease

Volumn 7, Issue 2, 2016, Pages

  Machado, M V ^a,b   Michelotti, G A ^a   Jewell, M L ^a   Pereira, T A ^a   Xie, G ^a   Premont, R T ^a   Diehl, A M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CASP2 PROTEIN, MOUSE; CASPASE 2;

ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY;

ANIMALS; CASPASE 2; DISEASE MODELS, ANIMAL; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84986268020     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.19     Document Type: Article

References (61)

1. WHO Media Center. Obesity and Overweight. Genebrem: Switzerland, 2013.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart L et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24: e13-e18.
3. Feng RN, Du SS, Wang C, Liu LY, Guo FC, Sun CH. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20: 17932-17940.
4. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; 2: 901-910.
5. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013; 10: 330-344.
6. Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 2004; 101: 2082-2087.
7. Sun Z, Miller RA, Patel RT, Chen J, Dhir R, Wang H et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med 2012; 18: 934-942.
8. Smagris E, BasuRay S, Li J, Huang Y, Lai KM, Gromada J et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 2015; 61: 108-118.
9. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007; 56: 2910-2918.
10. Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 2014; 15: 277-287.
11. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
12. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.
13. Bouchier-Hayes L, Green DR. Caspase-2: the orphan caspase. Cell Death Differ 2012; 19: 51-57.
14. Olsson M, Forsberg J, Zhivotovsky B. Caspase-2: the reinvented enzyme. Oncogene 2015; 34: 1877-1882.
15. Tiwari M, Sharma LK, Vanegas D, Callaway DA, Bai Y, Lechleiter JD et al. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. Autophagy 2014; 10: 1054-1070.
16. Wilson CH, Shalini S, Filipovska A, Richman TR, Davies S, Martin SD et al. Age-related proteostasis and metabolic alterations in Caspase-2-deficient mice. Cell Death Dis 2015; 6: e1597.
17. Gitenay D, Lallet-Daher H, Bernard D. Caspase-2 regulates oncogene-induced senescence. Oncotarget 2014; 5: 5845-5847.
18. Jobgen W, Fu WJ, Gao H, Li P, Meininger CJ, Smith SB et al. High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids 2009; 37: 187-198.
19. Johnson ES, Lindblom KR, Robeson A, Stevens RD, Ilkayeva OR, Newgard CB et al. Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. J Biol Chem 2013; 288: 14463-14475.
20. Machado MV, Michelotti GA, Pereira TD, Boursier J, Kruger L, Swiderska-Syn M et al. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut 2015; 64: 1148-1157.
21. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34: 616-621.
22. Oliveira RB, Maschio DA, Carvalho CP, Collares-Buzato CB. Influence of gender and time diet exposure on endocrine pancreas remodeling in response to high fat diet-induced metabolic disturbances in mice. Ann Anat 2015; 200: 88-97.
23. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 2013; 153: 747-758.
24. Kasuga M. Insulin resistance and pancreatic beta cell failure. J Clin Invest 2006; 116: 1756-1760.
25. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 2014; 7: 587-591.
26. Tao H, Zhang Y, Zeng X, Shulman GI, Jin S. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice. Nat Med 2014; 20: 1263-1269.
27. Bi P, Shan T, Liu W, Yue F, Yang X, Liang XR et al. Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med 2014; 20: 911-918.
28. Cheung KJ, Tzameli I, Pissios P, Rovira I, Gavrilova O, Ohtsubo T et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 2007; 5: 115-128.
29. Machado MV, Cortez-Pinto H. Management of fatty liver disease with the metabolic syndrome. Expert Rev Gastroenterol Hepatol 2014; 8: 487-500.
30. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P et al. Liver fibrosis, but no other histologic features, associates with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 149: 389-397.
31. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008; 118: 3331-3342.
32. Kumar S, Kinoshita M, Dorstyn L, Noda M. Origin, expression and possible functions of the two alternatively spliced forms of the mouse Nedd2 mRNA. Cell Death Differ 1997; 4: 378-387.
33. Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 2010; 285: 3428-3438.
34. Tinahones FJ, Coin Araguez L, Murri M, Oliva Olivera W, Mayas Torres MD, Barbarroja N et al. Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration. Diabetes Care 2013; 36: 513-521.
35. Keuper M, Wernstedt Asterholm I, Scherer PE, Westhoff MA, Moller P, Debatin KM et al. TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma. Cell Death Dis 2013; 4: e474.
36. Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol 2015; 208: 501-512.
37. Heinonen S, Saarinen L, Naukkarinen J, Rodriguez A, Fruhbeck G, Hakkarainen A et al. Adipocyte morphology and implications for metabolic derangements in acquired obesity. Int J Obes 2014; 38: 1423-1431.
38. Wree A, Schlattjan M, Bechmann LP, Claudel T, Sowa JP, Stojakovic T et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism 2014; 63: 1542-1552.
39. Petaja EM, Sevastianova K, Hakkarainen A, Orho-Melander M, Lundbom N, Yki-Jarvinen H. Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype. Obesity 2013; 21: 1174-1179.
40. Le Lay S, Krief S, Farnier C, Lefrere I, Le Liepvre X, Bazin R et al. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 2001; 276: 16904-16910.
41. Tsakiridis T, Wang Q, Taha C, Grinstein S, Downey G, Klip A. Involvement of the actin network in insulin signalling. Soc Gen Physiol Ser 1997; 52: 257-271.
42. Farnier C, Krief S, Blache M, Diot-Dupuy F, Mory G, Ferre P et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord 2003; 27: 1178-1186.
43. Xu XJ, Gauthier MS, Hess DT, Apovian CM, Cacicedo JM, Gokce N et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res 2012; 53: 792-801.
44. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461.
45. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (Lausanne) 2015; 6: 55.
46. Xiao L, Yang X, Lin Y, Li S, Jiang J, Qian S et al. Large adipocytes function as antigen-presenting cells to activate CD4 T cells via upregulating MHCII in obesity. Int J Obes 2013; 40: 112-120.
47. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009; 29: 1575-1591.
48. Ho LH, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S. A tumor suppressor function for caspase-2. Proc Natl Acad Sci USA 2009; 106: 5336-5341.
49. Nutt LK, Margolis SS, Jensen M, Herman CE, Dunphy WG, Rathmell JC et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005; 123: 89-103.
50. Andersen JL, Johnson CE, Freel CD, Parrish AB, Day JL, Buchakjian MR et al. Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J 2009; 28: 3216-3227.
51. Oliver TG, Meylan E, Chang GP, Xue W, Burke JR, Humpton TJ et al. Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop. Mol Cell 2011; 43: 57-71.
52. Guha M, Xia F, Raskett CM, Altieri DC. Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene 2010; 29: 1280-1292.
53. Shalini S, Dorstyn L, Wilson C, Puccini J, Ho L, Kumar S. Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ 2012; 19: 1370-1380.
54. Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY et al. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013; 62: 3697-3708.
55. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med 2013; 19: 557-566.
56. Stenson BM, Ryden M, Venteclef N, Dahlman I, Pettersson AM, Mairal A et al. Liver X receptor (LXR) regulates human adipocyte lipolysis. J Biol Chem 2011; 286: 370-379.
57. Zhang Y, Padalecki SS, Chaudhuri AR, De Waal E, Goins BA, Grubbs B et al. Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev 2007; 128: 213-221.
58. Sjogren K, Hellberg N, Bohlooly YM, Savendahl L, Johansson MS, Berglindh T et al. Body fat content can be predicted in vivo in mice using a modified dual-energy X-ray absorptiometry technique. J Nutr 2001; 131: 2963-2966.
59. Michelotti GA, Xie G, Swiderska M, Choi SS, Karaca G, Kruger L et al. Smoothened is a master regulator of adult liver repair. J Clin Invest 2013; 123: 2380-2394.
60. Fink T, Zachar V. Adipogenic differentiation of human mesencgymal stem cells, In: Vemuri MC, Chase LG, Rao MS (editors). Mesenchymal Stem Cells Assays and Applications. Springer: New York, USA, 2011.
61. Zebisch K, Voigt V, Wabitsch M, Brandsch M. Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal Biochem 2012; 425: 88-90.